1. Influenza A (H5N1): an overview of the current situation;Melidou;Eurosurveillance,2009
2. World Health Organization (WHO) Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO, 6 May 2010 Global alert and response (GAR) http://www.who.int/csr/disease/avian_influenza/country/cases_table_2011_03_07/en/index.html
3. World Health Organization (WHO) Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses for the development of candidate vaccine viruses for pandemic preparedness, February 2011 http://www.who.int/csr/disease/avian_influenza/guidelines/2011_02_h5_h9_vaccinevirusupdate.pdf
4. Update on Avian Influenza A (H5N1) virus infection in humans;Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus;N Engl J Med,2008
5. European Committee for Proprietary Medicinal Products (CHMP) Guideline on influenza vaccine prepared from viruses with the potential to cause a pandemic and intended for use outside of the core dossier context (EMEA/CHMP/VWP/263499/2006)